Connect with us
Novartis CEO said that the pharmaceutical company's strategy involves not exceeding acquisitions of more than $5 billion. The agreement with Cytokinetics meant a larger investment, since,...
XRHealth has offices in Barcelona and Sydney, as well as an Innovation and Development center in Tel Aviv, and has sixty employees. The American company offers...
The intraday minimum was marked at 10:31 a.m., with 8.22 euros, after the stock spent an hour and a half in a volatility auction trying to...
In June 2023, the HumanITCare closed a collaboration agreement with Clínicas Mi to accompany cancer patients throughout their treatment, from any location, 24 hours a day,...
Atrys advances in its purpose of promoting the company's organic growth in its three strategic areas. The company achieved a turnover of €169.5 million in the...
Novo Nordisk has entered independent research collaboration agreements with Omega Therapeutics and Cellarity to develop innovative therapeutic approaches for cardiometabolic diseases, with each company potentially receiving...
Alfasigma's Spanish subsidiary is expanding its facilities in Tortosa, Barcelona, to increase production capacity. The subsidiary, created in 2015 through the merger of Sigma-Tau and Alfa...
Spanish pharma companies started the year maintaining the red of the previous year. In Q1, the aggregate capitalization registered a drop of 10.57%, with values such...
Oryzon plans to maintain its share capital at €3.03 million and seek admission for new shares on Madrid, Barcelona, Bilbao, and Valencia Stock Exchanges. The biopharmaceutical...
The gross operating result (Ebitda) reached €97.1 million in the first half of 2023, 16% less than in the first six months of 2022. Operating income...